These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20869214)

  • 21. The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice.
    Pinto Lde F; Compri CM; Fornari JV; Bartchewsky W; Cintra DE; Trevisan M; Carvalho Pde O; Ribeiro ML; Velloso LA; Saad MJ; Pedrazzoli J; Gambero A
    Liver Int; 2010 Apr; 30(4):603-10. PubMed ID: 20088867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
    Cong WN; Tao RY; Tian JY; Liu GT; Ye F
    Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of hypolipidemic activity of synthetic gallic acid-linoleic acid ester with mixture of gallic acid and linoleic acid, gallic acid, and linoleic acid on high-fat diet induced obesity in C57BL/6 Cr Slc mice.
    Jang A; Srinivasan P; Lee NY; Song HP; Lee JW; Lee M; Jo C
    Chem Biol Interact; 2008 Jul; 174(2):109-17. PubMed ID: 18571153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent exercise prevents high-fat-diet-induced macrovesicular hepatic steatosis.
    Gauthier MS; Couturier K; Latour JG; Lavoie JM
    J Appl Physiol (1985); 2003 Jun; 94(6):2127-34. PubMed ID: 12547845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice.
    Tomas E; Wood JA; Stanojevic V; Habener JF
    Regul Pept; 2011 Aug; 169(1-3):43-8. PubMed ID: 21549160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consumption of barley beta-glucan ameliorates fatty liver and insulin resistance in mice fed a high-fat diet.
    Choi JS; Kim H; Jung MH; Hong S; Song J
    Mol Nutr Food Res; 2010 Jul; 54(7):1004-13. PubMed ID: 20112296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet.
    Fernandes-Santos C; Carneiro RE; de Souza Mendonca L; Aguila MB; Mandarim-de-Lacerda CA
    Nutrition; 2009; 25(7-8):818-27. PubMed ID: 19268533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
    Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet.
    Fraulob JC; Souza-Mello V; Aguila MB; Mandarim-de-Lacerda CA
    Clin Sci (Lond); 2012 Aug; 123(4):259-70. PubMed ID: 22420611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inflammatory profile and liver damage of a sucrose-rich diet in mice.
    Oliveira LS; Santos DA; Barbosa-da-Silva S; Mandarim-de-Lacerda CA; Aguila MB
    J Nutr Biochem; 2014 Feb; 25(2):193-200. PubMed ID: 24445044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromium attenuates high-fat diet-induced nonalcoholic fatty liver disease in KK/HlJ mice.
    Chen WY; Chen CJ; Liu CH; Mao FC
    Biochem Biophys Res Commun; 2010 Jul; 397(3):459-64. PubMed ID: 20513351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bifidobacterium adolescentis supplementation ameliorates visceral fat accumulation and insulin sensitivity in an experimental model of the metabolic syndrome.
    Chen J; Wang R; Li XF; Wang RL
    Br J Nutr; 2012 May; 107(10):1429-34. PubMed ID: 21914236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exercise training attenuates lipectomy-induced impaired glucose tolerance in rats.
    Coelho DF; Gualano B; Artioli GG; Roschel H; Amano M; Benatti FB; Fernandes T; Bueno CR; Câmara NO; Lancha AH
    Endocr Regul; 2009 Jul; 43(3):107-16. PubMed ID: 19817505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel agonist of PPAR-γ based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance.
    Zheng H; Li S; Ma L; Cheng L; Deng C; Chen Z; Xie C; Xiang M; Jiang W; Chen L
    Eur J Pharmacol; 2011 Jun; 659(2-3):244-51. PubMed ID: 21463618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of calorie restriction on SIRT1 expression in liver of nonalcoholic fatty liver disease: experiment with rats].
    Chen LL; Deng XQ; Li NX
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1434-7. PubMed ID: 17785073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of exercise on hepatic gene expression in an obese mouse model using cDNA microarrays.
    Lee KY; Kim SJ; Cha YS; So JR; Park JS; Kang KS; Chon TW
    Obesity (Silver Spring); 2006 Aug; 14(8):1294-302. PubMed ID: 16988071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of non-alcoholic fatty liver disease and insulin resistance by feeding a high-fat diet in rats: does coenzyme Q monomethyl ether have a modulatory effect?
    Safwat GM; Pisanò S; D'Amore E; Borioni G; Napolitano M; Kamal AA; Ballanti P; Botham KM; Bravo E
    Nutrition; 2009; 25(11-12):1157-68. PubMed ID: 19592219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the detraining status on high-fat diet induced fat accumulation in the adipose tissue and liver in female rats.
    Yasari S; Dufresne E; Prud'homme D; Lavoie JM
    Physiol Behav; 2007 Jun; 91(2-3):281-9. PubMed ID: 17449070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic ultrastructural enhancement due to telmisartan plus sitagliptin treatment in diet-induced obese C57BL/6 mice.
    Souza-Mello V; Gregório BM; Relvas-Lucas B; da Silva Faria T; Aguila MB; Mandarim-de-Lacerda CA
    Pancreas; 2011 Jul; 40(5):715-22. PubMed ID: 21602737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exercise without dietary changes alleviates nonalcoholic fatty liver disease without weight loss benefits.
    Ok DP; Ko K; Bae JY
    Lipids Health Dis; 2018 Sep; 17(1):207. PubMed ID: 30172252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.